These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [The characteristics of postinfarct stenocardia and the recurrence of a myocardial infarct after thrombolytic therapy]. Chernetsov VA Voen Med Zh; 1998 Sep; 319(9):59-63. PubMed ID: 9817019 [No Abstract] [Full Text] [Related]
26. [The treatment of acute cerebral infarction with urokinase and tissue plasminogen activator]. Araki G Nihon Rinsho; 1993 Nov; 51 Suppl():449-57. PubMed ID: 8283700 [No Abstract] [Full Text] [Related]
27. [New thrombolytic agents in myocardial infarction]. Charbonnier B; Lang M; Brochier M Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222 [TBL] [Abstract][Full Text] [Related]
28. [Systemic thrombolytic treatment in myocardial infarct]. Davi R; Copello F; Pareti G; Freggiaro V; Morelloni S; Corazza M; Fasciolo L; Allegri M Clin Ter; 1990 Aug 15-31; 134(3-4):223-35. PubMed ID: 2147625 [No Abstract] [Full Text] [Related]
29. New thrombolytic drugs in acute myocardial infarction: theoretical and practical considerations. Verstraete M Circulation; 1987 Aug; 76(2 Pt 2):II31-8. PubMed ID: 3111745 [No Abstract] [Full Text] [Related]
30. Role of the nurse in thrombolytic therapy. Albarran J; Kapeluch H Br J Nurs; 1994 Feb 10-23; 3(3):104-9. PubMed ID: 8148624 [TBL] [Abstract][Full Text] [Related]
31. Acute myocardial infarction. A guide for North Carolina doctors. Williams ML; O'Meara JJ; Tate DA; Simpson RJ N C Med J; 1995 Aug; 56(8):390-7. PubMed ID: 7566193 [No Abstract] [Full Text] [Related]
32. [Thrombolysis in acute myocardial infarct: prerequisites, current experiences and remaining problems]. Rapold HJ Schweiz Med Wochenschr; 1986 Aug; 116(33):1074-87. PubMed ID: 3094141 [TBL] [Abstract][Full Text] [Related]
33. [Intravenous and intracoronary thrombolysis in the treatment of myocardial infarction]. Tendera M; Ochała A Kardiol Pol; 1986; 29(10):689-97. PubMed ID: 3586471 [No Abstract] [Full Text] [Related]
34. Plasminogen depletion during streptokinase treatment or two-chain urokinase incubation correlates with decreased clot lysability ex vivo and in vitro. Onundarson PT; Haraldsson HM; Bergmann L; Francis CW; Marder VJ Thromb Haemost; 1993 Dec; 70(6):998-1004. PubMed ID: 8165625 [TBL] [Abstract][Full Text] [Related]
35. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy. Crabbe SJ; Grimm AM; Hopkins LE Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889 [TBL] [Abstract][Full Text] [Related]
36. [Plasminogen activators as thrombolytic agents in myocardial infarction]. Chamone DA; Massumoto C; Fujimura AY; Pileggi F; Bellotti G Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(6):288-94. PubMed ID: 2518605 [TBL] [Abstract][Full Text] [Related]
37. A review of fibrinolytic therapy in acute myocardial infarction. Cockins KA; Jain AC; Morgan DZ W V Med J; 1985 Sep; 81(9):191-4. PubMed ID: 3904213 [No Abstract] [Full Text] [Related]
38. [t-PA in thrombolytic therapy of acute myocardial infarct]. Rutsch W; Schmutzler H Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690 [TBL] [Abstract][Full Text] [Related]